Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2012
09/04/2012CA2476581C Wheat detecting method
09/04/2012CA2445370C Method of reducing analysis time of endpoint-type reaction profiles
09/04/2012CA2432971C Polypeptides
09/04/2012CA2351982C Selection and uses of lactic acid bacteria strains modulating non-specific immunity
09/04/2012CA2295865C Method for diagnosing alzheimer disease
08/2012
08/30/2012WO2012116371A1 Methods and compositions for determining virus susceptibility to integrase inhibitors
08/30/2012WO2012116294A1 Presence of erg gene rearrangements and protein over-expression in low grade pin (lg-pin) in prostate biopsies
08/30/2012WO2012116289A2 Microbial signatures as indicators of radiation exposure
08/30/2012WO2012116229A2 Compositions and methods for personal tumor profiling treatment
08/30/2012WO2012116220A2 Materials and methods for detection of hpv nucleic acid
08/30/2012WO2012116191A1 Rotation-dependent transcriptional sequencing systems and methods of using
08/30/2012WO2012116146A1 Use of template switching for dna synthesis
08/30/2012WO2012116122A2 A protein expression-based classifier for prediction of recurrence in adenocarcinoma
08/30/2012WO2012116111A1 METHOD AND COMPOUNDS FOR GENERATION OF iPSCs
08/30/2012WO2012116074A1 Biomarkers of insulin sensitivity
08/30/2012WO2012115968A2 Methods of weed control involving aad-1 plants, and re-plant and/or pre-emergence herbicide applications
08/30/2012WO2012115885A1 Circulating biomarkers
08/30/2012WO2012115789A2 Recurrent spop mutations in prostate cancer
08/30/2012WO2012115604A1 Mean dna copy number of chromosomal regions is of prognostic significance in cancer
08/30/2012WO2012115493A2 Biomarker for cancer, and cancer diagnosis using same
08/30/2012WO2012115464A2 Composition for hot-start pcr comprising blocking oligonucleotide
08/30/2012WO2012115454A2 Method for concentrating cells that are genetically altered by nucleases
08/30/2012WO2012115409A2 Method for using an enzyme resistant to high pressures
08/30/2012WO2012115270A1 Method for selecting ips cell clone, and method for selecting gene used in method for selecting same
08/30/2012WO2012115238A1 Method of visually determining site of origin of urine odor formation
08/30/2012WO2012115153A1 Cell evaluation method, cell culture method, cell evaluation device, incubator, cell evaluation program, colony classification program, stem cell culture method, stem cell evaluation device, and stem cell evaluation program
08/30/2012WO2012115068A1 Method of detecting mutant fgfr4 in breast cancer
08/30/2012WO2012114312A2 Exogenous internal positive control
08/30/2012WO2012114189A1 Method for predicting survival of glioblastoma patient using a ten-mirna signature
08/30/2012WO2012114075A1 Method for processing maternal and fetal dna
08/30/2012WO2012113965A1 Method for obtaining data that can be used to evaluate, predict and/or prognosticate response to treatment with pyrimidine analogues
08/30/2012WO2012113954A1 Novel method for in vitro mutagenesis and cloning by means of reverse pcr for cloning
08/30/2012WO2012113948A1 Method for determining genetic predisposition to parkinson's disease
08/30/2012WO2012113819A1 Molecular biomarkers for predicting response to antitumor treatment in lung cancer
08/30/2012WO2012113780A1 Method for quantifying human dna
08/30/2012WO2012113773A1 Diagnosis of ischemia using sflt-1 and hgf after intervention as an early indicator of complication
08/30/2012WO2012113760A1 Method of predicting the evolution of a patient suffering of stroke
08/30/2012WO2012113699A1 Mass spectrometric determination of the inhibitory effect of substances on beta-lactamases
08/30/2012WO2012113577A1 Method for quantifying human dna using an internal control
08/30/2012WO2012113266A1 Antibody and antigen recognizing tumor-initiating cells and use thereof
08/30/2012WO2012113072A1 A method for the selection of dna ligands for a molecular target
08/30/2012WO2012113064A1 Method of diagnosing primary mediastinal b-cell lymphoma or classical hodgkin lymphoma by detecting functional mutation at ciita locus.
08/30/2012WO2012113061A1 Cancer diagnosis and treatment
08/30/2012WO2012096646A9 Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles
08/30/2012WO2012094081A3 System and method for identifying and applying peripheral treatment mechanisms for disease
08/30/2012WO2012073498A3 Sugarcane-stalk-sugar-content-related marker and the use thereof
08/30/2012WO2012073495A3 Sugarcane-stalk-number-related marker and the use thereof
08/30/2012WO2012073493A3 Sugarcane-sugar-yield-related marker and the use thereof
08/30/2012WO2012057591A3 Resistance gene to xanthomonas axonopodis in soybeans
08/30/2012WO2012050353A3 Method whereby the base sequence of a target polynucleotide is non-specifically extended
08/30/2012WO2012049228A3 Marker sequences for multiple sclerosis and the use thereof
08/30/2012WO2012048106A3 Biomarkers useful to predict mek inhibitor drug efficacy
08/30/2012WO2012019175A8 Production of malonyl-coa derived products via anaerobic pathways
08/30/2012WO2011091324A8 Methods of generating zinc finger nucleases having altered activity
08/30/2012US20120222173 Plants with increased resistance to diabrotica virgifera and ostrinia nubilalis
08/30/2012US20120222171 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
08/30/2012US20120222153 Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
08/30/2012US20120222151 Disease resistant tomato plants
08/30/2012US20120222141 Islet1 (isl1) and hearing loss
08/30/2012US20120222139 Cancer Specific Mitotic Network
08/30/2012US20120220751 Non-Fluorescent Quencher Compounds and Biomolecular Assays
08/30/2012US20120220672 Presence of ERG Gene Rearrangements and Protein Over-expression in Low Grade PIN (LG-PIN) in Prostate Biopsies
08/30/2012US20120220671 Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome
08/30/2012US20120220661 Methods of modulation of branched chain acids and uses thereof
08/30/2012US20120220645 Genetic changes in atm and atr/chek1 as prognostic indicators in cancer
08/30/2012US20120220610 Inhibitions of glutaminase c
08/30/2012US20120220594 Methods for treating cancer in patients having igf-1r inhibitor resistance
08/30/2012US20120220582 Imidazopyrazine syk inhibitors
08/30/2012US20120220498 Fluorescence analyzing method, fluorescence analyzing apparatus and image detecting method
08/30/2012US20120220495 Arrays of microparticles and methods of preparation thereof
08/30/2012US20120220492 Viral Vectors with Improved Properties
08/30/2012US20120220491 Retentate chromatography and protein chip arrays with applications in biology and medicine
08/30/2012US20120220487 Determination of 17q Gain in Neuroblastoma Patients by Analysis of Circulating DNA
08/30/2012US20120220485 Probe set and method for identifying hla allele
08/30/2012US20120220483 Methods for fragmentation and labeling of nucleic acids
08/30/2012US20120220479 Probes for specific analysis of nucleic acids
08/30/2012US20120220477 Genetic markers associated with risk of diabetes mellitus
08/30/2012US20120220474 Methods and compositions for diagnosis of thyroid conditions
08/30/2012US20120220470 Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6
08/30/2012US20120220469 Toxicity typing using liver stem cells
08/30/2012US20120219985 Method for the toxicity assessments of nano-materials
08/30/2012US20120219984 Method for the anaerobic treatment of a wastewater and associated device
08/30/2012US20120219982 Methods for selecting active agents for cancer treatment
08/30/2012US20120219981 Mechanical stretching device
08/30/2012US20120219980 System and method for pipetting guidance
08/30/2012US20120219978 Method and System for Detection of Chloramphenicol
08/30/2012US20120219970 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
08/30/2012US20120219965 Masp 2, a complement-fixing enzyme, and uses for it
08/30/2012US20120219964 Bacterial atp synthase binding domain
08/30/2012US20120219960 Methods using pores
08/30/2012US20120219959 Targeted Chromosomal Mutagenesis Using Zinc Finger Nucleases
08/30/2012US20120219958 MicroRNA Signatures Differentiating Uterine and Ovarian Papillary Serous Tumors
08/30/2012US20120219957 Method of preparing a reaction mixture and related products
08/30/2012US20120219956 Ngal for diagnosis of renal conditions
08/30/2012US20120219954 Genotyping
08/30/2012US20120219952 Carbapenemase and antibacterial treatment
08/30/2012US20120219951 Probe, probe set, probe carrier, and testing method
08/30/2012US20120219950 Assay systems for detection of aneuploidy and sex determination
08/30/2012US20120219949 Method of detecting methylated dna in sample
08/30/2012US20120219948 Application of quantum dots for nuclear staining